0001209191-16-142199.txt : 20160920
0001209191-16-142199.hdr.sgml : 20160920
20160920201045
ACCESSION NUMBER: 0001209191-16-142199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160920
DATE AS OF CHANGE: 20160920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immune Design Corp.
CENTRAL INDEX KEY: 0001437786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262007174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 682-0645
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: VACCSYS INC
DATE OF NAME CHANGE: 20080617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Svennilson Peter
CENTRAL INDEX KEY: 0001606074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36561
FILM NUMBER: 161894769
MAIL ADDRESS:
STREET 1: C/O IMMUNE DESIGN CORP.
STREET 2: 1616 EASTLAKE AVE. E, SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-20
0
0001437786
Immune Design Corp.
IMDZ
0001606074
Svennilson Peter
C/O IMMUNE DESIGN CORP.
1616 EASTLAKE AVENUE. E., SUITE 310
SEATTLE
WA
98102
1
0
1
0
Common Stock
2016-09-20
4
P
0
800000
6.25
A
800000
I
See Footnote
Common Stock
3161942
I
See Footnote
The securities are directly held by The Column Group II, LP ("The Column Group II") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of The Column Group II. TCG II GP has voting and dispositive power with respect to the shares owned by The Column Group II. Mr. Svennilson is a managing partner of TCG II GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group II. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group II, except to the extent of his actual pecuniary interest therein.
The securities are directly held by The Column Group, LP ("The Column Group") and indirectly held by The Column Group GP, LP ("TCG GP"), the general partner of The Column Group. TCG GP has voting and dispositive power with respect to the shares owned by The Column Group. Mr. Svennilson is a managing partner of TCG GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group, except to the extent of his actual pecuniary interest therein.
/s/ Laura A. Berezin, Attorney-In-Fact
2016-09-20